Dalibor Pacík
Impact in
- Urology top 1%
- Urinary Bladder and Prostate Research
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
-
- Prostate Cancer Diagnosis and Treatment 14
- Prostate Cancer Treatment and Research 9
-
- Circular RNAs in diseases 4
- Co-authors
- Michal Fedorko (13 shared papers)Jan Doležel (12 shared papers)Ondřej Slabý (10 shared papers)Marek Svoboda (9 shared papers)Michal Staník (9 shared papers)Robert Iliev (5 shared papers)Christopher Dixon (6 shared papers)Lance A. Mynderse (6 shared papers)
- Journals
- The Journal of Urology (6 papers)Journal of Endourology (3 papers)Cancer Research (2 papers)Tumor Biology (2 papers)Urology (2 papers)
- Partner nations
- CzechiaUnited StatesGermany
In The Last Decade
Dalibor Pacík
53 papers receiving 995 citations
Peers
Comparison fields: 5 of 94
- Urology 281
- Cancer Research 322
- Pulmonary and Respiratory Medicine 456
- Rheumatology 183
- Molecular Biology 398
Countries citing papers authored by Dalibor Pacík
This map shows the geographic impact of Dalibor Pacík's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dalibor Pacík with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dalibor Pacík more than expected).
Fields of papers citing papers by Dalibor Pacík
This network shows the impact of papers produced by Dalibor Pacík. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dalibor Pacík. The network helps show where Dalibor Pacík may publish in the future.
Co-authors
The 25 scholars most cited alongside Dalibor Pacík, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 69 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 101 | |
| 2 | 2015 | 86 | |
| 3 | 2016 | 79 | |
| 4 | 2016 | 78 | |
| 5 | 2015 | 70 | |
| 6 | 2015 | 70 | |
| 7 | 2016 | 62 | |
| 8 | 2016 | 45 | |
| 9 | 2017 | 44 | |
| 10 | 2016 | 35 | |
| 11 | 2018 | 34 | |
| 12 | 2012 | 32 | |
| 13 | 2006 | 30 | |
| 14 | 2012 | 28 | |
| 15 | 2014 | 26 | |
| 16 | 2015 | 24 | |
| 17 | 2017 | 20 | |
| 18 | 2015 | 19 | |
| 19 | 1997 | 16 | |
| 20 | 2019 | 13 |
About Dalibor Pacík
Dalibor Pacík is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Surgery, Urology and Rheumatology, having authored 69 papers that have together received 1.0k indexed citations. Recurring topics across this work include Prostate Cancer Diagnosis and Treatment (14 papers), Urinary Bladder and Prostate Research (10 papers), Prostate Cancer Treatment and Research (9 papers), Pediatric Urology and Nephrology Studies (6 papers), Bladder and Urothelial Cancer Treatments (6 papers), Urologic and reproductive health conditions (5 papers), Urinary and Genital Oncology Studies (4 papers) and Circular RNAs in diseases (4 papers). The work is most often cited by research in Urology (281 citations), Cancer Research (322 citations), Pulmonary and Respiratory Medicine (456 citations), Rheumatology (183 citations) and Molecular Biology (398 citations). Dalibor Pacík has collaborated with scholars based in Czechia, United States and Germany. Frequent co-authors include Michal Fedorko, Jan Doležel, Ondřej Slabý, Marek Svoboda, Michal Staník, Robert Iliev, Christopher Dixon, Lance A. Mynderse, Lennart Wagrell and Thayne R. Larson. Their work appears in journals such as The Journal of Urology, Journal of Endourology, Cancer Research, Tumor Biology and Urology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.